reports
- ING Helpdesk
- Wim Lewi
VGP EPRA property tour to Berlin Ludwigsfelde
We visited Lidl and Zalando warehouse on the VGP Berlin park Ludwigsfelde (216k sqm). These are standard buildings of 12m high and 7 ton floor. Interestingly, there is a lot of manual labour, with an estimated 80% of labour coming out of Poland. The Polish border is 100km away and workers stay the week nearby in local housing to go back home for the weekend. The Ludwigsfelde site is about 20km out of Berlin on the A10, a big industrial artery (Tesla, etc…). VGP bought the land in 2014 and is st...
- Jacob Mekhael
MaaT Pharma 1H24 update extends runway into 2Q25, MaaT013 phase 3 topl...
MaaT reported 1H24 results, which come with an extension of the company's cash runway into 2Q25 (from 1Q25) through prioritisation of resources on the key programs for MaaT013 and MaaT033, while management confirmed they are exploring all options for additional funding. In addition, the company reiterates the timeline for the topline results from the phase 3 (ARES) trial of MaaT013 in aGvHD in Europe, which continue to be expected in mid-4Q24 – we view this as an important trigger for the compan...
- Guy Sips
- Hilde Van Boxstael
- Jacob Mekhael
- Michiel Declercq
- Wim Lewi
- Guy Sips
Barco We took ‘One Look' at Barco an decided to lower the barrier
In 1H24, Barco's business was impacted by customer destocking in the Meeting Experience and Healthcare segments. In Entertainment, customers delayed investments as a result of a weak film slate and in anticipation of Barco's upcoming product launches. While visibility remains low, Barco has reason to look forward to a very different 2H24. But we now think it will be even more back-end loaded and somewhat milder than we originally expected. We maintain our positive stance - albeit with a sl...
MaaT Pharma publie ses résultats semestriels 2024 et réalise un point ...
Lyon, France--(BUSINESS WIRE)-- Regulatory news: (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1 visant à améliorer la survie des patients atteints de cancers grâce à la modulation du système immunitaire, annonce aujourd’hui la publication de ses résultats financiers semestriels pour une période de 6 mois clôturée au 30 juin 2024 et réalise un point sur ses activités. « Forts des données positives présentées en avril 2024 lors du congrès de l'EBMT pour MaaT013 et du succès de not...
MaaT Pharma Publishes its Half Year 2024 Results and Provides a Busine...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through immune modulation, today announced its half year financial results for the six-month period ended June 30, 2024, and provided a business overview. “Building on the positive data for MaaT013 in April 2024 presented at the EBMT Congress, and the success of our recent fundraising, we have dedicated the first half of 2024 to pursuing recr...
- Sharad Kumar S.P
Holdings Report - August 2024 KBCS Holdings Universe Up 0.5% Thanks To...
1M Performance - Absolute: During July'24 (1M period), the KBCS Holdings Universe posted a return of 0.5% which was mainly driven by multi-asset holdings (+1.7%) while single-asset holdings posted a negative return of -1.3%. The 3 top performers during the period were HAL Trust (+5.1%), Texaf (+2.9%), and The Infrastructure Company (TINC, +9.6%) while the 3 worst performers were Brederode (-2.8%), Solvac (-5.3%), and Whitestone Group (-7.2%). YTD Performance - Relative: On a YTD basis (as of A...
GBLB GROUPE BRUXELLES LAMBERT SA
HAL HAL TRUST
DIE D'IETEREN SA
SOF SOFINA SA
SOLV SOLVAC S.A.
GIMB GIMV NV
QFG QUEST FOR GROWTH
ACKB ACKERMANS & VAN HAAREN NV
TUB FINANCIERE DE TUBIZE S.A.
HEIO HEINEKEN HOLDING N.V.
KBCA KBC ANCORA SCA
TEXF TEXAF
BREB BREDERODE S.A.
TINC TINC COMM. VA
ROCK WHITESTONE GROUP
- Hans D’Haese
- Stijn Demeester
Gimv/Model finetune post 1Q24/25 trading update/HOLD
In a 1Q24/25 trading update that was published last week, Gimv announced a continued solid portfolio performance resulting in a positive platform portfolio return of 3.5%. This has led to an improved NAV/share of €52 at end-June, to which should be added a further €0.5/share thanks to the sale of Mega International to Bizzdesign. This positive update provides some comfort for the remainder of the year. Moreover, it seems that the lull in private equity deal activity that traditionally marks summ...
MaaT Pharma: Information mensuelle relative au nombre total de droits ...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem TherapiesTM (MET)1 visant à améliorer la survie des patients atteints de cancers, publie le nombre d'actions composant son capital et le nombre total de droits de vote (articles L. 233-8 II du code de commerce et 223-16 du règlement général de l'AMF) au 31 août 2024. Place de cotation : Euronext Paris Code ISIN : FR0012634822 Site web : Date Nombre total d’actions composant le capital social ...
- ING Helpdesk
Benelux Morning Notes
ING Benelux Conference London: Aalberts, Arcadis, Azelis, Barco, Basic-Fit, Brunel International, DEME Group, Euronext, Fagron, Heijmans, Kinepolis, Lotus Bakeries, Melexis, Ontex, Randstad, Recticel, SBM Offshore, TKH Group, Van Lanschot Kempen Other company stories - OCI: Divestment of Methanol to Methanex for US$2.05bn, Staffing: US August temp volumes marginally better trend; NFP jobs miss
BFIT BASIC-FIT NV
SBMO SBM OFFSHORE NV
FAGR FAGRON SA
RAND RANDSTAD NV
LOTB LOTUS BAKERIES NV
REC RECTICEL SA
HEIJM HEIJMANS N.V. CERT
VLK
ARCAD VAN LANSCHOT KEMPEN NV CERT. OF SHS
AALB ARCADIS NV
OCI AALBERTS N.V.
BRNL OCI NV
ONTEX BRUNEL INTERNATIONAL N.V.
MELE ONTEX GROUP N.V.
TWEKA MELEXIS NV
KIN TKH GROUP N.V. CERT
BAR KINEPOLIS GROUP NV
AZE BARCO NV
DEME AZELIS GROUP NV
DEME GROUP NV
- ING Helpdesk
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Lynn Hautekeete
- Sharad Kumar S.P
- Wim Lewi
MaaT Pharma annonce sa participation à des conférences investisseurs e...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT : MAAT - la « Société »), société de biotechnologies en stade clinique avancé, leader dans le développement de Microbiome Ecosystem Therapies™ (MET)1 visant à améliorer la survie des patients atteints de cancers, annonce la présentation de deux posters lors du Congrès annuel de la « Society of Hematologic Oncology » qui se tiendra du 4 au 7 septembre 2024 à Houston, Texas aux États-Unis. MaaT Pharma annonce également que des membres de son équipe de direction participeront à trois conférences dédiées aux investisseurs en septembre. ...
MaaT Pharma To Present and Participate in Investor and Medical Confere...
LYON, France--(BUSINESS WIRE)-- Regulatory News: (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies™ (MET) dedicated to enhancing survival of patients with cancer, announced that it will present two posters at the Society of Hematologic Oncology Annual Meeting taking place September 4-7, 2024, in Houston, Texas, USA. In addition, MaaT Pharma announced that Company management will participate in three investor conferences in September. Details are as follows: Society of Hematologic Oncology Annual Meeti...
VGP’s ‘BBB-’ Credit Rating Reaffirmed by Fitch Ratings
VGP’s ‘BBB-’ Credit Rating Reaffirmed by Fitch Ratings PRESS RELEASE Regulated Information Antwerp, Belgium, 4 September 2024 (07.00 a.m. CET) VGP NV (‘VGP’ or ‘the Group’), a European provider of high-quality logistics and semi-industrial real estate, has had its credit rating reaffirmed by the Rating Agency Fitch Ratings (‘Fitch’). Fitch has reaffirmed the credit rating for VGP NV with a Long-Term Issuer Default Rating (IDR) and senior unsecured rating at 'BBB-'. The Outlook on the rating is Stable. Fitch stated: “The ratings reflect VGP’s continued discipline in managing dev...
VGP's 'BBB-' Kredietrating Herbevestigd door Fitch Ratings
VGP's 'BBB-' Kredietrating Herbevestigd door Fitch Ratings PERSBERICHT Gereglementeerde informatie Antwerpen, België, 4 september 2024 (07.00 a.m. CET) VGP NV ('VGP' of 'de Groep'), een Europese aanbieder van hoogstaand logistiek en semi-industrieel vastgoed, heeft zijn kredietrating herbevestigd gekregen van het ratingbureau Fitch Ratings ('Fitch'). Fitch heeft de kredietrating voor VGP NV met een 'Long-Term Issuer Default Rating' (IDR) en 'Senior Unsecured Rating' op 'BBB-' nogmaals bevestigd. Het vooruitzicht van de rating is stabiel. Fitch zei: “De ratings weersp...
- Sharad Kumar S.P
Gimv 1Q FY25 trading update: Wider discount opens up buying opportunit...
Gimv's 1Q trading update highlighted that portfolio return came in at 3.5%, which led to a growth in the NAVps which currently is €52.0ps, net of the €2.6ps dividend (July'24). During 1Q, Gimv's portfolio companies grew both revenues and margins and are well positioned to achieve double-digit growth during 2024. EBITDA growth has been the main driver of value creation which will also have a positive impact on NAV. Gimv has signed an agreement to sell its participation in 1 portfolio company whic...
- ING Helpdesk
- Jacob Mekhael
- Sharad Kumar S.P
- Wim Hoste
- Wim Lewi
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.